Ind-Swift Laboratories Limited
INDSWFTLAB · NSE · ₹386 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Ind-Swift Laboratories Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 25.4%; Net profit was ₹24.68 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹191 cr | +25.4% | Net profit: ₹25 cr | +181.3% | 12.9% | Company filing source |
| Mar 2026 | Revenue: ₹170 cr | +22.8% | Net profit: ₹15 cr | -93.2% | 8.9% | Company filing source |
| Dec 2025 | Revenue: ₹151 cr | — | Net profit: ₹10 cr | — | 6.3% | Company filing source |
| Sep 2025 | Revenue: ₹153 cr | — | Net profit: ₹8 cr | — | 5.2% | Company filing source |
| Jun 2025 | Revenue: ₹153 cr | +360.5% | Net profit: ₹9 cr | +837.8% | 5.7% | Company filing source |
| Mar 2025 | Revenue: ₹138 cr | — | Net profit: ₹222 cr | — | 160.8% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
ESSIX BIOSCIENCES LIMITED 37.8%ZEAL GLOBAL OPPORTUNITIES FUND 4.6%NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE 3.0%PANCHKULA FINVEST PRIVATE LIMITED 2.4%ASHOKKUMAR CHANDAK 2.2%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Shareholders meeting. Ind-Swift Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. …
05 Oct 2026 · document
- Certificate under SEBI (Depositories and Participants) Regulations, 2018. Certificate under Regulation 74(5) of SEBI (Depositories and Participant), Regulations…
05 Oct 2026 · document
- Shareholders meeting. Ind-Swift Laboratories Limited has informed the Exchange regarding Proceedings of 31st Annual General Meeting held on September 30, 2026.…
30 Sep 2026 · document
- General Updates. Intimation to the shareholders of physical securities pursuant to SEBI Master Circular no. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024…
28 Sep 2026 · document
- Ind-Swift Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201…
28 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Ind-Swift Laboratories Limited has informed the Exchange about Schedule of meet…
23 Sep 2026 · document
- General Updates. Ind-Swift Laboratories Limited has informed the Exchange about Disclosures under Regulation 29(2) of the SEBI (Substantial Acquisition of Share…
21 Sep 2026 · document
- Allotment of Securities. Ind-Swift Laboratories Limited has informed the Exchange regarding allotment of 70,00,000 Fully Convertible Warrants on Preferential Ba…
17 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time